Exact Mass: 843.3610143999999

Exact Mass Matches: 843.3610143999999

Found 12 metabolites which its exact mass value is equals to given mass value 843.3610143999999, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Proglumetacin

N-[4-(3-{4-[2-({2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetyl}oxy)ethyl]piperazin-1-yl}propoxy)-1-(dipropylcarbamoyl)-4-oxobutyl]benzenecarboximidic acid

C46H58ClN5O8 (843.3973698)

M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AB - Acetic acid derivatives and related substances C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

methyl 8-{[N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl]oxy}nonanoate

C35H59N2O21- (843.3610143999999)

methyl 8-{[N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl]oxy}nonanoate

C35H59N2O21- (843.3610143999999)

DDHepalpha1-6DDHepalpha1-2DDHepalpha1-2DDHepalphaO[CH2]3NH2

C31H57NO25 (843.3219512000001)

FC131 (TFA)

C38H48F3N11O8 (843.3639244)

FC131 TFA is a CXCR4 antagonist, inhibits [125I]-SDF-1 binding to CXCR4, with an IC50 of 4.5 nM. Anti-HIV activity[1].

methyl (1r,2r,4s)-4-{[(2r,4s,5s,6s)-4-(dimethylamino)-5-{[(2s,4s,5s,6s)-4-hydroxy-5-{[(2r,3s,6s)-3-hydroxy-6-methyl-5-oxooxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7,12-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

methyl (1r,2r,4s)-4-{[(2r,4s,5s,6s)-4-(dimethylamino)-5-{[(2s,4s,5s,6s)-4-hydroxy-5-{[(2r,3s,6s)-3-hydroxy-6-methyl-5-oxooxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7,12-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate

C42H53NO17 (843.3313327999999)

2-[(2-{[2-({2-[(4-amino-8-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-1,3-dihydroxyoctylidene)amino]-1,3-dihydroxypropylidene}amino)-1-hydroxy-5-(n-hydroxyformamido)pentylidene]amino}-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene)amino]-5-(n-hydroxyformamido)pentanoic acid

2-[(2-{[2-({2-[(4-amino-8-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-1,3-dihydroxyoctylidene)amino]-1,3-dihydroxypropylidene}amino)-1-hydroxy-5-(n-hydroxyformamido)pentylidene]amino}-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene)amino]-5-(n-hydroxyformamido)pentanoic acid

C34H53N9O16 (843.3610097999999)

(2s)-2-{[(2r)-2-{[(2s)-2-{[(2r)-2-{[(3s,4s)-4-amino-8-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-1,3-dihydroxyoctylidene]amino}-1,3-dihydroxypropylidene]amino}-1-hydroxy-5-(n-hydroxyformamido)pentylidene]amino}-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-5-(n-hydroxyformamido)pentanoic acid

(2s)-2-{[(2r)-2-{[(2s)-2-{[(2r)-2-{[(3s,4s)-4-amino-8-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-1,3-dihydroxyoctylidene]amino}-1,3-dihydroxypropylidene]amino}-1-hydroxy-5-(n-hydroxyformamido)pentylidene]amino}-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-5-(n-hydroxyformamido)pentanoic acid

C34H53N9O16 (843.3610097999999)